CD8A and neoplasm: HPV E7 contains a dominant CD8+ T cell epitope and vaccination with a synthetic peptide representing this epitope generates effective primary as well as recall CD8+ T cell responses against TC-1 tumor as demonstrated by us and others [24], [25], [42].